R&D investment in the biotech sector grows by 5.2% to 1,282 million euros 11/06/2025 In 2023, the activity of biotech companies in Spain generated more than 13,000 million euros of income, which represents... AseBio
AbilityPharma’s IBRILATAZAR (ABTL0812) doubles overall survival in patients with squamous ... 05/06/2025 Healthcare Innovative drugs Advanced therapies These results support ibrilatazar as a potential backbone therapy for patients with one of the most common subtypes of... Partners - Ability Pharmaceuticals
Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clini... 04/06/2025 Healthcare Access to innovation Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma... Partners - THERIVA BIOLOGICS S.L.
Genetics Becomes an Ally for Healthcare Professionals 03/06/2025 Healthcare Access to innovation Digitalization Personalized medicine is no longer a promise—it's a reality, with genetics as its key ally. To bring this knowledge into... Partners - ADNTRO GENETICS SL
BCN HEALTH publishes a study highlighting the substantial healthcare costs associated with... 03/06/2025 Healthcare Access to innovation BCN HEALTH has published the study ‘Hepatocellular carcinoma: what are the differential costs compared to the general... Partners - BCN Health
Accelerating molecular discovery using an in silico design platform 08/07/2025 Healthcare Access to innovation Drug discovery Innovative drugs Advanced therapies Industrial biotechnology Join our free event on Tuesday, July 8th at the Parque Científico de Barcelona for an extended version of our Lunch and... Partners
#NewAseBioMember | “#NewAseBioMember | “AseBio is the meeting point for all companies that... 02/06/2025 Healthcare Corporate Meet our new member Microviable Therapeutics . We sponke with Claudio Hidalgo Cantabrana, CEO. AseBio - MICROVIABLE THERAPEUTICS
BioDuro hosts webinar: "Exploring Peptide In-Vitro ADME Properties – From Natural Peptides... 30/05/2025 Healthcare Drug discovery Innovative drugs Advanced therapies The webinar exploring the in-vitro ADME (Absorption, Distribution, Metabolism, and Excretion) properties of peptide... Partners - BIODURO
University of Barcelona Science Park ecosystem holds steady with €124 million in investmen... 28/05/2025 Healthcare Industrial biotechnology Talento The 86 spin-offs, start-ups and scale-ups operating in the PCB collectively secured €124.7 million in funding in 2024... Partners - Parc Científic de Barcelona
World Multiple Sclerosis Day | “The integration of biotechnology and AI allows us to move ... 30/05/2025 Healthcare Personalized medicine Advanced therapies Interview with Mireia Forner, Medical Head of Neurology at Sanofi Iberia, a company working to change how multiple... AseBio - SANOFI
